Press Releases - 2021-09-22

Date	Title	Company
22-Sep-2021	Patient Access Solutions Market 2021\| Key Development To Be Observed Industry States And Outlook Across By 2028	The Wire Times
22-Sep-2021	BRITS IGNORE THEIR EYE HEALTH AND MISS OUT ON ESSENTIAL EYE TESTS	Théa
22-Sep-2021	Computer Assisted Coding Market is Expected to Reach USD 8,148.53 Million & Grow at CAGR of 11.45% Forecast to 2021-2028	The Wire Times
22-Sep-2021	Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries	Pfizer and BioNTech
22-Sep-2021	China based CMS joins BaseLaunch as latest partner	BaseLaunch
22-Sep-2021	Changing attitudes to vaccination after the COVID-19 pandemic could increase adult vaccination rates, improving health outcomes over the longer term	GSK
22-Sep-2021	Dr John Brown, CBE to retire as Cell and Gene Therapy Catapult’s Chairman	Cell and Gene Therapy Catapult
22-Sep-2021	Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19	Lilly
22-Sep-2021	BD Completes Study Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage	BD
22-Sep-2021	Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients	Roche
22-Sep-2021	Theragnostics Announces Licensing Agreement for Development and Commercialization of One-Step PET Radiopharmaceuticals	Theragnostics
22-Sep-2021	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.	Johnson & Johnson
22-Sep-2021	Moberg Pharma receives approval from the EMA’s Paediatric Committee	Moberg Pharma
22-Sep-2021	NHS encourages people to get COVID booster jab as bookings open	NHS England
22-Sep-2021	Wave Healthcare Communications rebrands and announces new Board	Wave Healthcare Communications
22-Sep-2021	New NHS clinical leadership to support post-COVID challenges	NHS England
22-Sep-2021	Propofol production at Bachem - why it has been a success	Bachem
22-Sep-2021	DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder	DemeRx
22-Sep-2021	Vetter's Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral	Vetter
22-Sep-2021	p53 Prions - Novel Biomarker for Circulating Tumor Cells	OncoLab Diagnostics GmbH